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Generationoffunctionalcellsfromhumanpluripotentstemcells(PSCs)throughinvitrodifferentiationisapromisingapproachfordrug
screening and cell therapy. However, the observed large and unavoidable variation in the differentiation potential of different human
embryonic stem cell (hESC)/induced PSC (iPSC) lines makes the selection of an appropriate cell line for the differentiation of a particular
celllineagedifﬁcult.Here,wereportidentiﬁcationofWNT3asabiomarkercapableofpredictingdeﬁnitiveendoderm(DE)differentiation
potential of hESCs. We show that the mRNA level of WNT3 in hESCs correlates with their DE differentiation efﬁciency. In addition,
manipulations of hESCs through WNT3 knockdown or overexpression can respectively inhibit or promote DE differentiation in a
WNT3level-dependentmanner.Finally,analysisofseveralhESClinesbasedontheirWNT3expressionlevelsallowedaccurateprediction
of their DE differentiation potential. Collectively, our study supports the notion that WNT3 can serve as a biomarker for predicting DE
differentiation potential of hESCs.
INTRODUCTION
Humanembryonicstemcells(hESCs)andinducedpluripo-
tent stem cells (iPSCs) are promising cell sources for cell
therapy due to their capacity for unlimited self-renewal
as well as pluripotency (Robinton and Daley, 2012).
Currently, various in vitro differentiation protocols have
been developed for the generation of different functional
cell types. However, each of these differentiation protocols
is typically developed based on one or a limited number of
hESClinesandmaynotbeapplicabletoothercelllines(Co-
hen and Melton, 2011). Indeed, different hESC and iPSC
linesexhibitsubstantialvariationintheircapacitytodiffer-
entiate into different cell lineages (Bock et al., 2011; Osa-
fune et al., 2008). A recent genome-wide gene-expression
analysis of a large collection of hESC and iPSC lines gener-
ated a scorecard based on the expression level of  500 line-
age-speciﬁcgenes(Bocketal.,2011).However,thismethod
is technically complicated and not economical for routine
laboratory studies. Thus, a simple and economical experi-
mental approach for accurately predicting hESC and iPSC
differentiation potentials is needed. In addition, a recent
study demonstrated that expression of the miR-371-3 clus-
ter can predict the neural differentiation propensity of hu-
manPSCs(hPSCs;Kimetal.,2011),whichsuggeststhatthe
lineage-speciﬁc differentiation potential can be predicted
with the use of simple biomarkers. Here, we utilized a
well-established deﬁnitive endoderm (DE) differentiation
system (D’Amour et al., 2005; Jiang et al., 2007) that has
also been demonstrated to work very well in our lab (Jiang
et al., 2013), and established WNT3 as a biomarker capable
of predicting the DE differentiation potential of hESCs.
RESULTS AND DISCUSSION
To identify a biomarker capable of predicting the hESC
differentiation potential, we collected all of the hESC lines
in the Zhang lab (HES2, HES3, HUES8, H9.1, H9.2, and
MEL-1) and subjected them to a commonly used DE differ-
entiationprotocol(D’Amouretal.,2005;Jiangetal.,2013).
We previously conﬁrmed that CD184 and CD117 double-
positive cells could mark DE cells via an activin-A-based
hESC differentiation protocol (Jiang et al., 2013), which is
consistent with other reports (Nostro et al., 2011; Pan
et al., 2011). Hence, we measured the DE differentiation
efﬁciency by quantifying the percentage of CD184 and
CD117 double-positive cell populations using ﬂow cytom-
etry. Consistent with previous reports (Bock et al., 2011;
Osafune et al., 2008), we observed a variable efﬁciency for
DE differentiation ranging from 15.4% for H9.2 to 95.3%
for MEL-1 (Figure 1A). Further analysis of the differentia-
tion potential of the H9 cell lines maintained in different
labs using the same differentiation protocol revealed a
variable differentiation efﬁciency (Figure S1A available
online). In addition, we also observed a variable
46 Stem Cell Reports j Vol. 1 j 46–52 j June 4, 2013 j ª2013 The Authorsdifferentiationefﬁciencyofeachcelllinewhenitwasmain-
tained under different culturing conditions (Figure S1B).
Collectively, these results suggest that the differentiation
potentialofhESCsisaffectednotonlybytheirgeneticback-
groundbutalsobyotherfactors,includingaccumulatedge-
netic and epigenetic changes during long-term culturing.
To identify a molecular marker that can serve as an
indicator of the differentiaion potential of the cell lines
tested, we analyzed the expression levels of a group of
genes in hESCs that include pluripotent transcription
factors, modulators of various signaling pathways known
to be involved in DE differentiation (Mfopou et al.,
2010), and epigenetic factors implicated in DE differentia-
tion (Jiang et al., 2013). Among the genes analyzed, the
expression level of WNT3 in hESCs has the best correlation
with the DE differentiation potential (Figures 1B, 1C, and
Figure 1. The WNT3 Level in hESCs Correlates with the DE Differentiation Potential
(A) Different hESC lines have different capacities for DE differentiation. The efﬁciency of DE differentiation was measured by the
percentage of CD184 and CD117 double-positive cells after 4 days of induction.
(B) WNT3 messenger RNA (mRNA) levels in undifferentiated hESCs correlate with their DE differentiation efﬁciency after 4 days of
induction. HES3, H9.2, MEL-1 (MG3) cultured with feeder, HUES8 cultured with Matrigel-mTeSR1, and H9.1 and HES2 cultured under both
conditions were used in the differentiation assays. Shown is one representative result of three independent experiments.
(C) Immunoﬂuorescent staining images show a correlation between WNT3levels in hESCs and SOX17or FOXA2 expressionafter 4 days of DE
differentiation.
See also Figure S1.
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WNT3 and Endoderm Differentiation PotentialS1C), suggesting that the WNT3 expression level in hESCs
is a potential biomarker for predicting the DE differentia-
tion potential.
If the WNT3 expression level in hESCs is a true predictor
of the potential for DE differentiation, we anticipated that
manipulation of the WNT3 level in hESCs should affect
their DE differentiation capacity. To test for this possibility,
wedesignedﬁvedifferentsmallhairpinRNAs(shRNAs)that
target different regions of WNT3 and generated ﬁve stable
WNT3 knockdown HUES8 sublines. We ﬁrst conﬁrmed
that knockdown of WNT3 does not affect hESC mainte-
nance, as the expression of the pluripotent factors was
maintained in these WNT3 knockdown HUES8 sublines
(Figure S2A). We then subjected the parental HUES8 line
and derived sublines to the same differentiation protocol
and determined their DE differentiation efﬁciency, which
ranged from 10% to 80%, by quantifying the percentage
of CD184 and CD117 double-positive cells. Interestingly,
whenthedifferentiationefﬁciencyoftheseHUES8sublines
wasplottedagainsttheWNT3levelsintheundifferentiated
cell state, we observed an excellent correlation (Figure 2A).
Next, we asked whether the differentiation potential of a
‘‘poor’’ hESC line with a low DE differentiation potential
could be improved by enforced expression of WNT3.T o
this end, we constructed a doxycycline-inducible WNT3
overexpression lentiviral vector and transfected it into
H9.2, one of the hESC lines with a low endogenous
WNT3levelandlowDEdifferentiationpotential(Figure1).
We ﬁrst conﬁrmed that doxycycline is able to induce
WNT3 expression in this modiﬁed H9.2 hESC line in a
doxycycline dosage-dependent manner (Figure S2B). We
then conﬁrmed that doxycycline treatment does not alter
the expression of pluripotent genes (OCT4, NANOG, and
SOX2)o rAXIN2, a marker of canonical WNT/beta-catenin
activity (Figure S2B). This indicates that transient overex-
pression of WNT3 alone does not affect hESC mainte-
nance, and that WNT3 is functionally different from
WNT signaling pathway activation, which could induce
hESCs to differentiate (Davidson et al., 2012). After
4 days of culturing under different concentrations of doxy-
cycline, these cells were subjected to DE differentiation
(without doxycycline). We found that doxycycline-
induced WNT3 expression in undifferentiated H9.2 cells
improved their differentiation efﬁciency, and, more impor-
tantly, the improvement occurred in a WNT3 dosage-
dependent manner (Figure 2B). Collectively, the above
results support our observation that the DE differentiation
potential correlates with WNT3 expression levels in hESCs.
To evaluate the predictive potential of WNT3,w ep e r -
formed the same differentiation experiment at Duke
University using all of the hESC/hiPSC lines available in
the Bursac lab (including hESC lines HES3 [NKX2-5-GFP],
H7, and H9 and MEL-1 [NKX2-5-GFP], and hiPSC line
JT16). We ﬁrst analyzed the WNT3 expression level in these
cell lines by quantitative PCR (qRT-PCR), which allowed us
torankorderthesecelllinesbasedontheirWNT3expression
levels. We then subjected these cell lines to differentiation
and quantiﬁed their differentiation efﬁciencies. In almost
perfect agreement with our prediction, we found that the
differentiation efﬁciency is highly correlated with the
WNT3levelsofthesehESC/hiPSClines(Figure2C),conﬁrm-
ing the predictive capacity of WNT3. To further support our
cell-surface-marker-basedﬂuorescence-activatedcellsorting
(FACS)results,weanalyzedtheexpressionofendodermline-
age markers and pluripotent genes after DE differentiation.
We chose two hESC lines (H7 [low WNT3] and MEL-1
[highWNT3])basedontheirendogenousWNT3expression
levels. The results shown in Figure 2D clearly demonstrate
that the expression levels of a panel of DE marker genes are
higher in MEL-1 compared with the H7 cell line, suggesting
a correlation between their DE differentiation potential and
the endoderm marker gene-expression levels in hESCs.
Activin/Nodal-SMAD2/3 signaling is necessary and sufﬁ-
cient for human endoderm induction (Brown et al., 2011;
D’Amour et al., 2005), but many other signaling pathways,
particularly the WNTsignaling pathway (Bone et al., 2011;
Hayetal.,2008),alsomodulateDEdifferentiation(Mfopou
et al., 2010). We recently reported that WNT signaling ex-
hibited a biphasic role in modulating DE differentiation
of hESCs, as treatment with either the WNT agonist
Wnt3a at the beginning of differentiation or the WNT
antagonist XAV 939 at a later stage of differentiation, or
both, could increase DE differentiation (Jiang et al.,
2013). To test whether the capacity of the WNT3 expres-
sion level in hESCs to predict the DE differentiation poten-
tial would still be applicable under these differentiation
conditions, we assayed four differentiation conditions
with ﬁve different hESC lines (HUES8, HES2, HES3, H9.1,
and MEL-1). The results shown in Figure 2E demonstrate
that the WNT3 expression levels in hESCs were still corre-
lated with their DE differentiation efﬁciency under the
different differentiation conditions (Figure 2E). These
results indicate that although different differentiation pro-
tocolsmightresultinvariabledifferentiationefﬁciency,the
predictive capacity of the WNT3 expression level in hESCs
is not affected by differentiation conditions.
Thus far, we have demonstrated an excellent correlation
between WNT3 levels in hESCs and their DE differentia-
tion potential. However, it is not clear whether the variable
WNT3 levels in hESC lines can also serve as a predictor
when the hESCs are subjected to differentiation for other
lineages. To address this question, we further characterized
the WNT3-depleted HUES8 line. First, qRT-PCR analy-
sis demonstrated that WNT3 knockdown upregulated neu-
roectoderm lineage marker gene expression when treated
under the neuroectoderm differentiation condition
48 Stem Cell Reports j Vol. 1 j 46–52 j June 4, 2013 j ª2013 The Authors
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WNT3 and Endoderm Differentiation Potential(Figure S2C). Second, immunostaining revealed that
WNT3 knockdown increased the PAX6- or NESTIN-posi-
tive neural lineage cell population when the cells were sub-
jected to further neural differentiation (Figure S2D). These
data suggest that WNT3 knockdown in hESCs can increase
their neuroectoderm differentiation potential. We then
evaluated the effect of WNT3 knockdown in hESCs on
their potential for differentiation toward the mesendo-
derm lineage, the common precursor for mesoderm and
DE. qRT-PCR analysis demonstrated that WNT3 knock-
downinhESCsresultedinimpairedactivationofmesendo-
derm marker gene expression after a 1.5 day differentiation
treatment (Figure S2E). Moreover, variable cardiomyo-
cyte (mesoderm derivate) differentiation efﬁciency was
observed among the different hESC lines, with MEL-1
(highest WNT3 level) generating more beating cells than
H9 and H7 when they were subjected to the same differen-
tiationprocedure(datanotshown).Thisresultisconsistent
with the observation that MEL-1 exhibited the highest DE
differentiation potential (Figure 2C). Collectively, these
Figure 2. WNT3 Is a Functional Bio-
marker for Predicting the DE Differentia-
tion Potential
(A) WNT3 levels in control and various
knockdown HUES8 sublines correlate with
their DE differentiation efﬁciency. Five
shRNAs and one control shRNA were used to
generate HUES8 sublines.
(B) Overexpression of WNT3 in the H9.2
hESC line in the undifferentiated state can
improve the DE differentiation efﬁciency.
The improvement correlates with the level
of WNT3 expression.
(C) Independent veriﬁcation of the pre-
dictive potential of WNT3 using different
hPSC lines maintained in a different lab.
hiPSC line JT16 and hESC lines HES3 (NKX2-
5-GFP), H9, MEL-1 (NKX2-5-GFP), and H7
cultured on feeder or deﬁned E8 system
were used in this assay.
(D) qRT-PCR analysis of the expression of
endoderm lineage genes and pluripotent
genes after DE differentiation. Two cell
lines, H7 and MEL-1, were chosen for this
analysis based on their endogenous WNT3
expression levels in the undifferentiated
state. Shown is one representative result
(with SD from three technical replicates) of
two independent experiments.
(E) Four previously described protocols
(Jiang et al., 2013) were used to differen-
tiate hESCs into DE, and the correlations
between the WNT3 expression level of
undifferentiated hESCs and the DE differ-
entiation efﬁciency were analyzed. The four
protocolsincludedthefollowingtreatments
in a serum-free medium: (1) A - > A (Activin
A only for 4 days); (2) AW - > A (Activin A
and Wnt3a for 2 days followed by Activin A
only for another 2 days); (3) A - > AX
(Activin A only for 2 days followed by
Activin A and XAV 939 for another 2 days);
and (4) AW - > AX (Activin A and Wnt3a for
2daysfollowedbyActivinAandXAV939for
another 2 days).
See also Figure S2.
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WNT3 and Endoderm Differentiation Potentialresults raised the possibility that WNT3 levels in hESCs
may predict not only the DE differentiation potential but
also the mesoderm (positive correlation) and neuroecto-
derm (negative correlation) differentiation potentials.
Further studies are needed to quantitatively evaluate the
correlation between the WNT3 expression level in hESCs
and their differentiation potential for mesoderm and neu-
roectoderm lineages.
To begin to understand why the WNT3 levels in hESCs
can serve as a biomarker for predicting the DE
differentiation potential, we asked whether higher levels
of WNT3 in hESCs can alter the expression levels of key
DE differentiation genes. To this end, we induced the
expression of WNT3 at different levels using the induc-
ible WNT3-overexpression hESC line (Figure S2B).
Although WNT3 overexpression did not signiﬁcantly
alter the expression levels of pluripotent genes (Fig-
ure S2B), it upregulated a panel of key endoderm lineage
genes, including EOMES, FOXA2, GATA6, GSC, MIXL1,
NODAL and SOX17. However, the expression levels of
these genes were still much lower compared with those
in differentiated DE (Figure 3A). Interestingly, the expres-
sion levels of these endoderm genes in the various hESC
lines generally correlated with their DE differentiation
Figure 3. Dox-Induced WNT3 Expression
in hESCs Correlates Positively with the
Expression Level of a Panel of Factors
Important for Endoderm Differentiation
(A) qRT-PCR analysis demonstrates that
Dox-induced WNT3 expression in hESCs
correlates with the expression of a panel of
factors important for DE differentiation.
However, the increased levels of the endo-
derm factors are not sufﬁcient to drive DE
differentiation. Data are shown with the SD
from three biological replicates. The p value
by Student’s t test compared with ‘‘no dox’’
isshownas#p>0.05,*p<0.05,**p<0.01.
Differentiated DE samples serve as control.
(B) Statistically signiﬁcant correlations
between the mRNA levels of the endoderm
maker genes NODAL, MIXL1, and EOMES in
hESCs and the DE differentiation efﬁciency
of the various hESC lines.
(C) Hypothetic model explaining how the
WNT3levelinhESCsmight beabletopredict
the DE differentiation potential. Left panel:
The pluripotency of hESCs is independent of
WNT3, and variable WNT3 expression levels
exist in hESC lines. Right panel: hESCs
withhigherWNT3expression.Keyendoderm
lineage factors are upregulated, which may
render the hESCs poised for DE differ-
entiation pending downregulation of the
pluripotent factors by other differentiation
signals.
See also Figure S3.
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WNT3 and Endoderm Differentiation Potentialpotential (Figures 3B and S3A). NODAL, MIXL1, and
EOMES exhibited a statistically signiﬁcant correlation
(p < 0.05; Figure 3B), although it was not as good as
that of WNT3 based on the coefﬁcient R
2 value (Fig-
ure 1B). Importantly, EOMES (EOMESODERMIN),
which interacts with SMAD2/3 to initiate the transcrip-
tional network governing endoderm formation, has
been reported to mark the onset of endoderm speciﬁca-
tion (Teo et al., 2011). These data suggest that WNT3-
mediated upregulation of key DE differentiation genes
could predispose hESCs to DE differentiation. However,
it is currently unclear how WNT3 upregulation leads to
higher levels of endoderm marker gene expression in
hESCs. The facts that the expression level of AXIN2,a
canonical WNT signaling pathway marker, did not
exhibit a signiﬁcant change in WNT3-overexpression
hESCs (Figure S2B), and that no signiﬁcant correlation be-
tween AXIN2 and DE differentiation capacity was
observed (Figure S1C) suggest that the canonical WNT
signaling pathway may not be the key factor behind
WNT3’s capacity to predict the DE differentiation poten-
tial. Consistent with this notion, treatment of hESCs with
Wnt3a, a WNT agonist, did not signiﬁcantly alter DE dif-
ferentiation efﬁciency (Figures S3B and S3C). The use of
recombinant WNT3 protein may help convert ‘‘poor’’
hESC lines with a low DE differentiation potential into
‘‘good’’ ones with a high DE differentiation potential.
AlthoughtheexactmechanismbywhichWNT3levelsin
hESCs predict their differentiation potential is not known,
weproposeaworkingmodelthatcanexplainallofourdata
so far (Figure 3C). It has been established that the identity
of hESCs is mainly determined by the core pluripotency
regulatory networks (Boyer et al., 2005). Variable levels of
lineage factors, such as WNT3, can be tolerated in hESCs,
which is supported by the fact that knockdown or overex-
pression of WNT3 in hESCs does not affect pluripotent
geneexpression(FigureS2).However,itislikelythathigher
levels of WNT3 could result in upregulation of multiple
factors critical for DE differentiation, rendering the hESCs
poised for DE differentiation. Upon receiving other differ-
entiation signals that downregulate the pluripotency
transcription network, hESCs could initiate differentiation
toward DE. Consistent with this hypothesis, a recent study
demonstratedthatalthoughconstitutiveoverexpressionof
SOX17 in hESCs does not affect hESC maintenance, it can
restrict hESCs to DE lineage differentiation (Se ´guin et al.,
2008).
In summary, we have identiﬁed WNT3 as a biomarker
capable of predicting the DE differentiation potential of
hESC lines. WNT3 appears to be a functional marker,
because the DE differentiation potential can be modulated
by altering WNT3 levels in hESCs. Our study establishes a
simple method for predicting the DE differentiation poten-
tial of hESCs, which should facilitate efforts to understand
and generate endoderm cell lineages.
EXPERIMENTAL PROCEDURES
hESC Maintenance and DE Differentiation
hESC line HUES8 was cultured in Matrigel-coated dishes with
mTeSR1 medium (STEMCELL Technologies) according to the
manufacturer’s instructions. hESC line MEL-1 and HES3 with
INS-GFP reporter (Micallef et al., 2012) were cultured on mito-
mycin C inactivated mouse embryonic ﬁbroblast (iMEF) with
regular hESC medium (Dulbecco’s modiﬁed Eagle’s medium
[DMEM]/F12, 20% (vol/vol) knockout serum replacement, 1%
(vol/vol) nonessential amino acids, 1% (vol/vol) GlutaMax, 1%
(vol/vol) penicillin-streptomycin, 55 mM b-mercaptoethanol sup-
plemented with 8 ng/ml FGF2 (PeproTech)). Three H9 lines of
different origin (H9.1 from the Zhang lab, H9.2 from the Bursac
Lab, and H9.3 from the Deng lab (Peking University; Jiang et al.,
2007) and the HES2 line were cultured either on iMEF with regular
hESCmediumoronMatrigel-coated disheswithmTeSR1medium.
Only those cells with undifferentiated morphology were used for
the DE differentiation assay.
For Figures 2C and 2D, the hESC lines H7, H9, MEL-1, and HES3
with NKX2-5-GFP reporter (Elliott et al., 2011), and hiPSC line
JT-16 were cultured on iMEF with regular hESC medium. H7
cultured on deﬁned Essential 8 Medium (Invitrogen) was also
used in one experiment. The experiments shown in Figure 2C
and 2D were performed in the Bursac lab.
For DE differentiation, routinely cultured hESCs with undiffer-
entiated morphology were replated into Matrigel-coated multi-
well plates with ESC medium. To measure the correlation between
gene expression and DE differentiation efﬁciency, we used half of
the cells for gene-expression analysis and the other half for the
subsequent DE differentiation assay. One day later, the cells
were washed twice with DMEM/F12 and then cultured for
4 days in basal medium (DMEM/F12, 55 mM 2-mercaptoethanol,
1% [vol/vol] nonessential amino acids, 0.5% [vol/vol] B27
without vitamin A [Invitrogen], 0.25% [vol/vol] N2 [Invitrogen])
supplemented with 100 ng/ml recombinant human activin A
(PeproTech) or other growth factors or chemicals (available
upon request; murine Wnt3a [PeproTech, 50 ng/ml] and XAV
939 [Tocris, 1 mM]) were used for Figure 2E). The medium was
changed every day.
Statistical Analysis
All data are representative of three or more experiments. Errors are
the standard deviation (SD) of averaged results. Correlation anal-
ysis was performed with GraphPad Prism software, and R
2 and
p values are presented. Brieﬂy, the coefﬁcient of determination,
R
2, was calculated to determine how well a regression line ﬁt the
set of data. The signiﬁcance (probability) of the correlation coefﬁ-
cient was determined from the t statistic, which indicates whether
the observed correlation coefﬁcient would have occurred by
chance if the true correlation was zero.
More detailed information can be found in Supplemental
Experimental Procedures, and details regarding the primers used
in this work are provided in Table S1.
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